InsidersTradesSigma
Total declarations
Companies
▲ Purchases (17 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
17
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Sumitomo Chemical Co., Ltd., Representative Director & President. Officer active across 2 companies, notably Myovant Sciences Ltd.. In total, 19 filings have been published. Split: 17 buys · 1 sell. Total volume traded: €1.4bn. Activity tracked since 16 August 2021. The latest transaction was filed on 22 June 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sumitomo Chemical Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
15,116,277 shares@ US$8.60100.0% of flowCommon SharesSEC:0000899243-23-016487:0
51,599,200 shares@ US$27.0098.1% of flowCommon SharesSEC:0000899243-23-007864:0
Canonical exit: 8 Jun 2023 (T+90)
4,243,005 shares0Common SharesSEC:0000899243-23-007110:0
20,677 shares@ US$22.84580.0% of flowCommon StockSEC:0000899243-21-038387:0
Canonical exit: 27 Dec 2021 (T+90)
36,000 shares@ US$23.40410.1% of flowCommon StockSEC:0000899243-21-038083:0
Canonical exit: 23 Dec 2021 (T+90)
84,018 shares@ US$21.95970.1% of flowCommon StockSEC:0000899243-21-037631:0
Canonical exit: 21 Dec 2021 (T+90)
38,273 shares@ US$22.09570.1% of flowCommon StockSEC:0000899243-21-037114:0
Canonical exit: 19 Dec 2021 (T+90)
50,000 shares@ US$21.7510.1% of flowCommon StockSEC:0000899243-21-036597:0
Canonical exit: 15 Dec 2021 (T+90)
65,128 shares@ US$22.03720.1% of flowCommon StockSEC:0000899243-21-036290:0
Canonical exit: 13 Dec 2021 (T+90)
30,000 shares@ US$25.1130.0% of flowCommon StockSEC:0000899243-21-035821:0
Canonical exit: 9 Dec 2021 (T+90)
21,902 shares@ US$25.73570.0% of flowCommon StockSEC:0000899243-21-035564:0
Canonical exit: 7 Dec 2021 (T+90)
29,822 shares@ US$26.73810.1% of flowCommon StockSEC:0000899243-21-035342:0
Canonical exit: 2 Dec 2021 (T+90)
40,000 shares@ US$24.82570.1% of flowCommon StockSEC:0000899243-21-035135:0
Canonical exit: 30 Nov 2021 (T+90)
70,000 shares@ US$23.91570.1% of flowCommon StockSEC:0000899243-21-034765:0
Canonical exit: 28 Nov 2021 (T+90)
40,000 shares@ US$22.67280.1% of flowCommon StockSEC:0000899243-21-034525:0
Canonical exit: 24 Nov 2021 (T+90)
34,299 shares@ US$22.370.0% of flowCommon StockSEC:0000899243-21-034281:0
Canonical exit: 22 Nov 2021 (T+90)
46,478 shares@ US$20.86020.1% of flowCommon StockSEC:0000899243-21-034046:0
Canonical exit: 18 Nov 2021 (T+90)
17,116 shares@ US$21.44730.0% of flowCommon StockSEC:0000899243-21-033840:0
Canonical exit: 16 Nov 2021 (T+90)
42,785 shares@ US$21.29380.1% of flowCommon StockSEC:0000899243-21-033476:0
Canonical exit: 14 Nov 2021 (T+90)
19 of 19 declarations
About Sumitomo Chemical Co., Ltd.
Sumitomo Chemical Co., Ltd. is a Representative Director & President. The person has 19 filings in total, and within the 19 sampled filings the buy activity spans 2021-08-18 to 2023-06-26, with sum_buy_eur of 1329165339 and sum_sell_eur of 118624985. The companies mentioned are Myovant Sciences Ltd. and Roivant Sciences Ltd.
